PALI: Palisade Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3.07
Enterprise Value ($M) -4.08
Book Value ($M) 5.33
Book Value / Share 1.21
Price / Book 0.58
NCAV ($M) 5.03
NCAV / Share 1.14
Price / NCAV 0.61

Profitability (mra)
Return on Invested Capital (ROIC) -2.40
Return on Assets (ROA) -1.04
Return on Equity (ROE) -1.31

Liquidity (mrq)
Quick Ratio 2.84
Current Ratio 2.84

Balance Sheet (mrq) ($M)
Current Assets 7.89
Assets 8.19
Liabilities 2.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -14.86
Net Income -14.44
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.19
Cash from Investing 0.00
Cash from Financing 9.58

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 127.08

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 21,392 100,278 21.33
2025-05-13 1,956,244 5,357,277 36.52
2025-05-12 7,080 57,014 12.42
2025-05-09 9,687 23,371 41.45

(click for more detail)

Similar Companies
ORGO – Organogenesis Holdings Inc. ORMP – Oramed Pharmaceuticals Inc.
OTLK – Outlook Therapeutics, Inc. PASG – Passage Bio, Inc.
PCSA – Processa Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io